In fact, our data indicate that RUNX2 induces the expression of CXCR4, which in turn promotes autophagy, cell invasiveness, and osteotropism, by inhibiting the mTOR signalling pathway in melanoma cells (Figure 8). The gene discussed is RUNX2; the disease is melanoma.